50 search results for the keyword shortage notice in latest news
Narrow your results
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Paracetamol 120mg and 240mg suppositories. MSN/2022/003 Tier 2 – medium impact Date of issue 26th January 2022 Paracetamol 120mg and 240mg suppositories are out of stock [...]
Published on: 26th January 2022 | Updated on: 26th January 2022
SDA/2021/006 (U) this update supercedes the advice provided in the previous alert SDA/2021/006 Date issued 28th October 2021 Champix® (varenicline) 0.5mg and 1mg tablets – Supply Disruption All Champix® (varenicline) products are unavailable until further notice. The Medicines and Healthcare [...]
Published on: 29th October 2021 | Updated on: 29th October 2021
Updated: 16/08/21 – the expiry date for Aprovel 150mg tablets batch 0R855 should be April 2023 MHRA Class 2 Medicines Recall: Irbesartan-containing products Drug alert number: EL (21)A/19 MDR Number: MDR 050-10/20 Date issued: 5th August 2021 The Medicines and [...]
Published on: 16th August 2021 | Updated on: 18th July 2022
MHRA Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products Drug alert number: EL (21)A/14 MDR Number: MDR 015-05/21 Date issued: 17th June 2021 The Medicines and Healthcare products Regulatory [...]
Published on: 17th June 2021 | Updated on: 17th June 2021
Update: 31.03.2021 All preparations of ranitidine (tablets, effervescent tablets, oral solution and injection) are out of stock until further notice. Following recent advice from the EMA, the MHRA have suspended all licenses for ranitidine products. Department of Health and Social Care [...]
Published on: 31st March 2021 | Updated on: 6th May 2022
